Sangeeta N. Bhatia, Director at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 2,584 shares at $466.29 ($1.2M) on 2024-08-08, disclosed to the SEC on 2024-08-12.
Scheduled sale ($1.2M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $466.29 | 1,292 | $602K | 50.0% |
| 2 | $466.29 | 1,292 | $602K | 50.0% |
| Total | $466.29 avg | 2,584 | $1.2M | 100% |
| Filing → |
| VRTX | SELL | 2025-08-29 | $206K | — | Filing → |
| VRTX | SELL | 2025-05-05 | $202K | — | Filing → |
| VRTX | SELL | 2024-09-04 | $323K | — | Filing → |